Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-23

Clinical Trial Update: Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis [Phase 2, Phase 3]

View source ↗

Summary

ClinicalTrials.gov reports on the efficacy evaluation of Qing Re Huo Xue, a Chinese herbal medicine, for rheumatoid arthritis in Phase 2 and Phase 3 trials, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Qing Re Huo Xue

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: COMPLETED